Pulse Biosciences (PLSE) Receivables (2021 - 2025)

Name: Pulse Biosciences (PLSE) Receivables (2021 - 2025) | Business Quant
Creator: Business Quant

Pulse Biosciences' quarterly Receivables came in at $274000.0 in Q4 2025, up 1726.67% quarter-over-quarter from $15000.0 in Q3 2025.

Pulse Biosciences has reported Receivables for 3 years, with the latest figure at $274000.0 in Q4 2025.

For the quarter ending Q4 2025, Receivables changed N/A year-over-year to $274000.0; the trailing twelve-month figure through Dec 2025 stood at $274000.0 (changed N/A YoY), and the FY2025 full-year result was $274000.0, changed N/A from the prior year.
Receivables for Q4 2025 stood at $274000.0, up from $15000.0 in the prior quarter.
The five-year high for Receivables was $274000.0 in Q4 2025, with the low at $5000.0 in Q3 2022.
Average Receivables over 3 years is $65142.9, with a median of $21000.0 recorded in 2022.
Peak annual rise in Receivables reached 93.06% in 2022, while the deepest fall reached 93.06% in 2022.
Tracing PLSE's Receivables over 3 years: stood at $61000.0 in 2021, then sank by 91.8% to $5000.0 in 2022, then surged by 5380.0% to $274000.0 in 2025.
The last three Receivables figures came in at $274000.0 (Q4 2025), $15000.0 (Q3 2025), and $5000.0 (Q3 2022), per Business Quant data.

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Receivables (Qtr)
1	Intuitive Surgical	156.17 Bn	151.78 Bn	1.83 Bn	1.62 Bn
2	Becton Dickinson	41.51 Bn	40.49 Bn	2.15 Bn	2.21 Bn
3	Resmed	30.43 Bn	28.77 Bn	890.98 Mn	1.05 Bn
4	West Pharmaceutical Services	22.78 Bn	22.26 Bn	296.40 Mn	701.00 Mn
5	Solventum	13.39 Bn	13.39 Bn	1.10 Bn	1.18 Bn
6	Cooper Companies	12.33 Bn	12.20 Bn	695.20 Mn	807.10 Mn
7	Align Technology	11.65 Bn	10.59 Bn	736.59 Mn	1.13 Bn
8	Baxter International	9.81 Bn	7.77 Bn	891.00 Mn	1.68 Bn
9	Aptargroup	7.39 Bn	7.19 Bn	351.91 Mn	846.13 Mn
10	Pulse Biosciences	1.72 Bn	1.72 Bn	-	274,000.00

Download Data 🔒